Kenkichi Nozaki

Kenkichi Nozaki practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

Kenkichi Nozaki's NPI, 1225246184, was assigned on May 21, 2007. Kenkichi Nozaki holds Alabama license 33432.

Kenkichi Nozaki's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

Kenkichi Nozaki's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Kenkichi Nozaki is also affiliated with UAB Hospital. The medical group on file is UAB Medicine.

Dmand AI tracks the electronic health record (EHR) system at each site where Kenkichi Nozaki practices. Vendor and product names are available with a free account.

Neurology is Kenkichi Nozaki's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Kenkichi Nozaki is licensed in Alabama.

CMS data shows 228 Medicare services from Kenkichi Nozaki across 8 procedure codes in 2024, for 96 Medicare patients. Medicare paid $12,414 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 96 Medicare patients who saw Kenkichi Nozaki in 2024. The largest group is 65 to 74, with 39 patients. 75% of them have high blood pressure, and 74% have arthritis. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kenkichi Nozaki's median patient age at 65, with 53% women.

In 2024, Kenkichi Nozaki wrote 677 Medicare Part D claims for 56 patients. 77% of them were for generic drugs. CMS names the drug for 630 of them, across 15 drugs with 11 or more claims each, at $1,977,139 in total drug cost. In 2023, CMS named 718 claims across 16 drugs.

Kenkichi Nozaki accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 16 papers to Kenkichi Nozaki, published from 2011 to 2019. 2011 was the busiest year, with 2. The most frequent topics are Calpain, Apoptosis and Central Nervous System Diseases. Kenkichi Nozaki has published most often in J Neurochem. Kenkichi Nozaki's most frequent co-authors are Thomas F. Scott, MD, Sarah Beth Breaux, MD and Ashok Chauhan, MD.

CMS Open Payments shows 11 general payments to Kenkichi Nozaki from 8 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 94% of the total. UCB, Inc. paid the most, $406.